FILE:MJN/MJN-8K-20120301153956.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
           
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
           
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
           
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
           
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
Item 5.02
                                            
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On March 1, 2012, Stanley D. Burhans was appointed as the new Vice PresidentFinance, Global Commercial Operations of Mead Johnson Nutrition Company (the "Company"), effective immediately.  As a result, Mr. Burhans will no longer serve as the Company's Vice President and Controller.  Until Mr. Burhans' successor is appointed, the Company has appointed Kathy A. MacDonald, 48, the Company's Vice President, Investor Relations, to serve as the Company's Acting Corporate Controller.
 
Ms. MacDonald
has been the Company's Vice President, Investor Relations since January 2011 and has been continuously employed by the Company or its former parent, Bristol-Myers Squibb Company, since 1988 in various capacities.  From February 2009 to December 2010, Ms. MacDonald served as Vice President, FinanceAsia and Europe and from October 2006 to January 2009, as Regional Director, FinanceAsia.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


